| Literature DB >> 24551763 |
Robab Nazarpour1, Ebrahim Zabihi2, Ebrahim Alijanpour3, Zeinab Abedian4, Hamid Mehdizadeh5, Fatemeh Rahimi3.
Abstract
Cryopreservation is the method of choice for long term storage of human PBMCs. This study was designed to compare the different combinations of variables affecting the cryopreservation of PBMCs samples. The viability of PBMCs separated from 2×5 ml peripheral blood samples obtained from 16 healthy adult volunteers, were measured using trypan blue dye exclusion method just before freezing with different concentrations of DMSO (10, 15, and 20%) and FBS (40 or 70%) at two different temperatures (either 4(o)C or 25(o)C). Then after 2 weeks the cells were thawed and the viability was measured again. Also the PBMCs response to PHA was measured after 48 h using MTT assay. The effects of the different variables were calculated and compared among the groups. A total of 192 PBMCs cryotubes made from blood samples of 16 volunteers were tested. The viability of the cells obtained by the two centrifugation procedure was the same (both more than 99%). The concentration of the FBS (40 vs 70%) did not show to have significant effects on either cells viability or response to PHA. On the other hand 20% DMSO concentration and freezing temperature at 25(o)C decreased both cells. Based on the obtained results, it is recommended to centrifuge the PBMCs under higher revolt speed at shorter time (700 g for 20 minutes) and decrease the FBS concentration to 40%. The DMSO concentration should be kept at 10-15% and the freezing medium be cooled down to 4(o)C.Entities:
Keywords: DMSO; FBS; PBMCs; ficol; freezing
Year: 2012 PMID: 24551763 PMCID: PMC3920500
Source DB: PubMed Journal: Int J Mol Cell Med ISSN: 2251-9637
Twelve freezing conditions (freezing medium temperature, DMSO and FBS concentration) used for cryopreservation of PBMCs for each sample
| Group Number | Group code | FBS (%) | DMSO (%) | Freezing Medium temp. (ºC) |
|---|---|---|---|---|
| I | 401004 | 40 | 10 | 4 |
| II | 401025 | 40 | 10 | 25 |
| III | 401504 | 40 | 15 | 4 |
| IV | 401525 | 40 | 15 | 25 |
| V | 402004 | 40 | 20 | 4 |
| VI | 402025 | 40 | 20 | 25 |
| VII | 701004 | 70 | 10 | 4 |
| VIII | 701025 | 70 | 10 | 25 |
| IX | 701504 | 70 | 15 | 4 |
| X | 701504 | 70 | 15 | 25 |
| XI | 702004 | 70 | 20 | 4 |
| XII | 702025 | 70 | 20 | 25 |
After gently mixing the cells corresponding freezing medium for each group, the PBMCs were transferred to 1.5 ml Cryotube® vials (Nalgene, UK) and stored in -80ºC overnight. Then the cryotubes were quickly transferred to a liquid nitrogen Dewar
Fig 2. Effects of different cryopreservation conditions on PBMCs response to phytohaemaglutinan-A (PHA) stimulation measured by MTT assay. Twelve groups (I to XII) with different concentrations of FBS (40 or 70%), DMSO (10,15, or 20%) at two different freezing medium temperature (4ºC or 25 ºC) have been tested, the code number for each group indicates the variables amount (FBS %-DMSO%-Temperature). The MTT assay was performed after 48 h. exposure to PHA. No significant difference was observed between groups
Fig 1Effects of different cryopreservation conditions on PBMCs viability using trypan-blue dye exclusion. Twelve groups (I to XII) with different concentrations of FBS (40 or 70%), DMSO (10,15, or 20%) at two different freezing medium temperature (4ºC or 25 ºC) have been tested, the code number for each group indicates the variables amount (FBS %-DMSO%-Temperature). Each group contains 16 cryotubes prepared from 16 different blood samples